Due to the increasing demand for healthcare services worldwide, there is a need for innovative changes in the provision of healthcare. The introduction of advanced practice nurse (APN)-and/or pharmacist-led outpatient clinics is an emerging trend in many countries. The Rheumatology Monitoring Clinic (RMC) started in Singapore General Hospital (SGH) in 2009, as a new healthcare delivery service model, led by APNs and pharmacists. The aim of the RMC is to ensure that stable patients with rheumatoid arthritis and spondyloarthritis on disease modifying anti-rheumatic drugs (DMARDs) are monitored regularly and appropriately for drug toxicity. The benefit of having such a model of care in a local tertiary centre is to deliver right-siting of care for stable patients, hence allowing more clinic slots for rheumatologists to see new patients, and those with complex diseases. A survey conducted on the RMC showed that it received positive feedback from patients, with an overall high degree of satisfaction. We thus established the acceptability of a non-physician-led clinic in our local setting. Based on the success of the RMC, the scope has been extended to monitor patients on newly initiated DMARDs and escalation therapy. Additionally, an APN-led telephone clinic (the Virtual Monitoring Clinic [VMC]) has been introduced, offering costeffective healthcare, personalised service, and convenience to patients. This review aims to summarise the role and model of care of a novel RMC in Singapore, discuss the key roles of APNs/pharmacists, and describe the outcomes of the RMC audit and survey.
INTRODUCTION

Background of Non-physician-led Clinics
Rheumatoid arthritis and spondyloarthritis are major systemic inflammatory arthritides. The quality of life of these patients is affected by the disease; they experience pain, stiffness, fatigue, disability, and other systemic manifestations. In the long-term, the disease has great impact on their self-esteem, psychosocial needs, relationships, and work 1 . It is important that this group of patients be managed holistically and monitored on a regular basis in terms of their response to treatment as well as their coping ability with the disease.
The need for long-term follow-up of chronic diseases has caused a greater demand on healthcare worldwide; leading to an emerging trend in hospitals of APN/pharmacist-led outpatient clinics 2, 3 . This has led to the extended roles of nurses and allied health professionals, which include assessment of patients, monitoring of patients on DMARDs, providing education, psychosocial support and counselling for patients, and education of staff 4, 5 . In addition, they may be trained to provide guidance on the use of analgesia, exercise techniques, goal setting and measurement of disease activity, and quality of life 6, 7 .
The role of allied health professionals in rheumatology has developed successfully with multi-disciplinary teams. Rheumatology nurseled clinics have been running in the United Kingdom (UK) since the late 1980s and function alongside rheumatologists' clinics 8 . For example, the role of the former in initiating or adjusting doses of DMARD therapy according to efficacy, Proceedings of Singapore Healthcare  Volume 22  Number 1  2013 toxicity, and tolerability has been described in a rheumatology clinic at Northumbria Healthcare NHS Foundation Trust 9 . Other examples of similar models of care are patients being referred to a nurse-led clinic following a consultation by the rheumatologist and initiation of DMARDs. They are regularly reviewed by the rheumatologist and nurse specialist at alternate visits ranging between four to six monthly intervals 6, 10 . The success of this form of non-physician-led clinic has also been well characterised in other disciplines; as illustrated in a study on a heart failure clinic staffed by APN and pharmacist specialist 11 . In this model of care, the job scope of the therapists include patient consultation, assessment, and drug titration. Prescriptive privileges for the nurse specialists vary with different countries ranging from independent prescribing, to supplementary, and patient group direction where prescribing is predetermined by protocols 12 .
In terms of outcomes, many studies on rheumatology nurse-led clinics have shown a positive influence on patients' perceived ability to cope; it also enhanced their self-care ability 6, 11, 13 . For example, a study conducted on a rheumatology drug monitoring clinic led by a rheumatology nurse specialist reported improvement in patients' Rheumatology Attitude Index, Arthritis Impact Measure Scales, and had positive influence on their ability to cope when compared with primary care clinics led by outpatient nurses. Additionally, patients have increased personal control and adjusted better to the impact of their rheumatoid arthritis 6 . Similar studies on nurse-led RMC reported greater satisfaction from patients and better symptom control compared with primary healthcare services, and were more cost-effective compared with in-patient and day care patient teams 7, 11, 13 . These clinics have also been shown to be both safe and effective 13 .
Although non-physician-led monitoring clinics have been well established in clinical practice in the UK 2, 3, 5, 6, [8] [9] [10] [11] , it remains a new concept in Singapore. In this review, we will discuss some important aspects of a Singapore-based RMC: (1) the purpose of having a RMC; (2) the structure and workflow of such a clinic; (3) its feasibility and acceptability in the local context; (4) the roles of the allied health therapists in relation to the RMC and (5) opportunities for expansion of the RMC, to improve health service related quality of care.
The Role of a Novel RMC in Singapore
The RMC is a new healthcare delivery model based at SGH, a large tertiary hospital. The RMC was initiated in March 2009, with the aim to ensure that stable patients diagnosed with inflammatory arthritis on drugs such as methotrexate, sulfasalazine, hydroxychloroquine, leflunomide, oral glucocorticoids, or non-steroidal anti-inflammatory drugs, are regularly monitored for side-effects of therapy. It is noteworthy that primary care physicians or general practitioners in Singapore do not routinely monitor rheumatology patients on DMARDs and hence this service is not readily available in the primary care setting. The benefit of having such a model of care at the RMC in a Singapore tertiary centre is specifically to deliver right-siting of care for stable patients, hence reducing the number of routine visits to rheumatologists and allowing more clinic slots for them to see new patients and those with on-going active or complex diseases.
To complement the RMC, a nurse educator works alongside, whose role is to empower patients to recognise and manage mild disease flares. As the principal role of the RMC is to monitor DMARDs toxicity, patients who require in-depth education on their disease process and management may be referred to the nurse educator, which is not part of the RMC. Nevertheless, patients attending the RMC are routinely counselled on drug toxicities, sideeffects, and adherence to therapy.
The Structure of the RMC (Fig.1 ) At the RMC, APNs and pharmacists are the lead providers in the clinic, working in collaboration with rheumatologists, and following a rigorous protocol 14 . The RMC consultations are led by either APNs or pharmacists, under the supervision of rheumatologists, who are on standby and thus available for discussion if needed. The therapists function as the primary contact point for patients with queries regarding the RMC (having one person as a contact point would facilitate patient care), and working closely with the lead consultant.
Patients with an established diagnosis of rheumatoid arthritis or spondyloarthritis on stable treatment, and deemed to be inactive or have stable disease activity (based on clinical and laboratory findings, and physician judgment) are referred to the RMC by their rheumatologists. These patients are seen by the RMC or rheumatologist at alternate Proceedings of Singapore Healthcare  Volume 22 Number 1  2013 visits. The interval between reviews is generally determined by which type of DMARD they are taking. To ensure that the RMC works within a tight clinical framework, standard reference guidelines are used for initiating, monitoring, and achieving target dose for DMARD therapy, in accordance with the (1) British Society of Rheumatology and British Health Professionals in Rheumatology 15 , and/or (2) American College of Rheumatology guidelines for the management of rheumatoid arthritis 16 .
Consequent to the RMC consultation, patients are issued with repeat prescriptions, assuming that their conditions remain stable and no adverse drug reactions are detected. In the event of a disease flare or complication arising from the medication or arthritis, this should be highlighted to the attending rheumatologist promptly and early specialist input would be provided. This will ensure early detection of drug toxicities and facilitate timely intervention of disease complications.
The Unique Roles of the Rheumatology APN and Pharmacist within the RMC
Patients enrolled into the RMC will be seen by either an APN or pharmacist. The roles of these two groups of allied health practitioners, within the context of the RMC, are practically synonymous. The only exception to this is that the pharmacists are not accredited to perform joint counts and hence do not compute disease activity scores for patients with rheumatoid arthritis, but this is not essential in fulfilling the aims of the RMC. The RMC started with pilot clinics consisting of a combined team of pharmacists and APNs from other disciplines. This was due to the fact that although a nurse had been identified to be trained in rheumatology, the APN training would take three years. While it can be argued that APNs may be more suitable for the role of the RMC, as they would have undergone advanced training and accreditation (Masters of Nursing), pharmacists can be privileged to write prescriptions for certain types of drugs, including Since the inception of the RMC, the frequency of the clinics has been two half-day sessions per week and increasing to five sessions per week in 2013. Each session is run by either an APN or pharmacist, who may be conducting the clinic concurrently depending on the logistics of clinic resources, such as the availability of consultation rooms. As both the RMC APN and pharmacist deliver the same service, the patients are not at liberty to choose whether they wish to see an APN or pharmacist. Nevertheless, they may select the sessions based on their preferred appointment day/time.
Advanced Practice Nurses (APNs)
The roles of APNs and APN-led clinics are still relatively new concepts in Singapore. The first cohort from the Master of Nursing programme from the National University of Singapore graduated in 2004 17 . To be certified as an APN in Singapore, a registered nurse needs to have at least three years post-graduate experience, an advanced education at the master's degree level, and fulfill competencies in a log-book under the supervision of a clinical preceptor for a year, as supported by the institution's director of nursing and clinical head of department. APNs are trained to diagnose and manage common medical conditions and work collaboratively with the medical teams and other multidisciplinary healthcare professionals to provide tertiary nursing care. At the RMC, APNs monitor the patients for medication toxicity and efficacy (by way of disease activity scores, pain scores, and acute phase reactants), as well as tolerability and adherence to therapy. Standard measurements such as blood pressure and joint counts for arthritis will be performed routinely. During a consultation, they also assess the patients' emotional feelings, discuss psychosocial issues, provide patient counselling, and make appropriate referrals to other allied health professionals such as occupational therapists, physiotherapists, podiatrists, or medical social workers as needed.
Pharmacists
Similar to an APN, the principal roles of the pharmacist at the RMC are monitoring and prescribing DMARDs, and counselling on medication adherence.
Education/Training and Accreditation
APNs and pharmacists undergo a period of education, training, and assessment prior to taking on the role of running the RMC. For initial privileging, this consists of an induction session provided by the lead rheumatologist, opportunities to sit in the rheumatology outpatient clinics (minimum of 30 hours of clinic attachment with three compulsory sessions at the consultant clinics), attending a total of four compulsory tutorials, and/or didactic lectures in core topics, namely rheumatoid arthritis, spondyloarthritis, monitoring of DMARDs, and approach to joint assessment, assessment through multiple choice questions (minimum requirement pass mark of 70%), and training in prescribing methods. The latter is carried out during the induction process and sit-in rheumatology outpatient clinics, through observation and hands-on training. Other forms of training include fulfillment of course work and completion of recommended reading material. Involvement in rheumatology research and audit mentored by rheumatology consultants are also encouraged. To date, the RMC therapists have participated in poster presentations at the SingHealth Annual Scientific Meeting and SingHealth Pharmacy Conference, an internal audit, and a survey study on patients' experiences. In order for the therapists to have prescribing privileges, they are credentialed by the hospital's Clinical Governance Board, which also reviews their annual reaccreditation. To maintain recertification, evidence of continual education, and fulfillment of a defined set of requirements as approved by the hospital's Clinical Governance Board are mandatory 18 . Quarterly meetings with the lead RMC consultant also provide a platform for further informal teaching and clarification of issues which may surface along the way.
AUDIT OF THE RMC
Up to March 2010, the RMC saw its first 200 patient attendances. An audit assessing the RMC's processes and compliance with the protocol was conducted over a one-year period, on 149 clinic attendances at the RMC. Other issues audited were case mix (diagnosis) of referrals, non-attendance rate, and potential safety issues. Of the 200 patient attendances, 51 were not audited. The latter consisted of a small number of patients attending the RMC in the first quarter of the 12-month audit time frame who were excluded due to the concurrent H1N1 outbreak in Singapore. Therefore we were unable to adhere to the predetermined standards for the workflow and operations due to multiple rescheduling of patients' appointments. The other cases were selected using simple random sampling from a list generated by the Health Information Management Services within the hospital. The audit found that patients were largely stable in their disease with few complications related to treatment, and the majority of patients were compliant with treatment. Of the seven patients (10%) who needed an unplanned change (either increment, reduction, or discontinuation) in their DMARD therapy, three of the incidents were due to side-effects of drugs (liver derangements and gastrointestinal sideeffects with methotrexate) and two were due to disease flares. These five patients were detected promptly by the RMC therapists and were seen by rheumatologists in a timely manner. Only 4% (n=6) of patients were unwilling to continue with subsequent follow-up at the RMC. The reasons included: (1) patient's refusal due to perceived 'lower quality of care' (n=1); (2) development of new co-morbidities (such as osteoarthritis, diabetes mellitus, and hypertension) for which therapists were not trained to manage (n=1); (3) patients requiring further DMARD titration due to unstable disease (n=2) and (4) patients' preferred day/time for appointment not available as the RMC only had sessions twice a week (n=2). The median non-attendance rate at the RMC was 10% (range 5-37), similar to the rheumatology specialist clinics. Potential safety issues highlighted by the audit were: (1) delay by the patients in doing blood tests, hence the therapists did not have access to results during the RMC consultation; (2) patients defaulting scheduled appointments (however, this was improved by having the therapists providing telephone reminders to patients 24-72h prior to appointments) and (3) patients obtaining extended medication without blood monitoring at the RMC. As rheumatologists were required to issue a contract prescription to cover the entire period until the patients were next seen by them, this could potentially be misused as a repeat prescription. Nevertheless, this issue was avoided by ensuring that the hospital's Pharmacy Department did not return the contract prescriptions to the patients after initial dispensing, thus restricting patients' access to repeat prescriptions until they were seen at the RMC. From the audit, we demonstrated that this clinic model was worthwhile from a clinical standpoint and the rheumatology service benefited from the added value of this new service.
PATIENTS' EXPERIENCE WITH THE RMC
As this is the first rheumatology DMARD monitoring clinic in Singapore managed by allied health professionals, we conducted a survey of patient experience 19 , obtaining feedback from patients, rheumatologists, APNs, and pharmacists, through a set of pre-determined questionnaires. The results of the study were subsequently used to guide us in improving delivery of clinical service and quality of care. From this survey, we were able to demonstrate the degree of patient and physician satisfaction with the RMC, and have attempted to illustrate some reasons behind them. This indirectly contributed to our understanding of patients' perceptions regarding such a novel service and model of care in Singapore. Results revealed that of the 105 patients surveyed, a total of 97 (92.4%) patients were satisfied/strongly satisfied with the overall service, and none were dissatisfied; 96% felt that the APNs/pharmacists provided clear and detailed information about their disease and medication, while 92% of patients were confident they knew what side-effects were possible. Ninety-two percent of patients were more likely to adhere to treatment, and 93% of patients were willing to come back for follow-up at the RMC. There was no difference in patient satisfaction in the average Likert summed scores, between the APNs and pharmacists. Age, gender, ethnicity, and underlying disease did not exert any influence on the responses. All the rheumatologists surveyed were satisfied with the patients' management and professionalism of the therapists. They opined that the RMC freed up time for them to see more patients with complex rheumatic conditions (as opposed to doing routine monitoring). This study reflected the acceptability of a non-physicianled clinic in our local setting and highlighted the usefulness of having a regular clinic for monitoring medication toxicity and for patient education. These findings were consistent with other studies 20, 21 , which evaluated the acceptability and impact of nurse-led monitoring clinics. Patients valued their experience at the RMC, and similarly, it was well received by rheumatologists. This study also highlighted certain workflow issues that will require further audit and intervention in order to improve the quality of point-of-care service. As the questionnaire was developed anew and has not been previously validated in other studies, it is important to have future studies evaluate and measure outcomes of how patient counselling and education may lead to a better understanding of their disease and medication, improve adherence to therapy, blood monitoring, and clinic attendance.
GROWTH AND FUTURE PLANS FOR THE RMC
Over a three-year period (2009-2012), the numbers of patients seen at the RMC have progressively increased (Fig. 2) . For example, the average number of patients seen per month in 2009 and 2012 were 12 and 61, respectively. In view of the acceptability and value add shown by the RMC, the service has been expanded from two clinics per week at inception, to five in 2013. Additionally, the scope of the RMC has been recently upgraded to include the monitoring of patients during initiation of a new DMARD and up-titration of the dose, following a pre-defined algorithm and tight clinical framework (Fig. 3 ). This will serve to enhance the roles of the APN/pharmacist and contribute to freeing up more slots for rheumatologists to see new cases. To support the expansion of the service, we have also engaged a locum general practitioner to join the current workforce of the RMC.
Based on the success of the current on-site RMC, an APN-led telephone monitoring clinic, known as the Virtual Monitoring Clinic (VMC), has been introduced. Information and communication technology such as telemedicine are increasingly used to monitor, diagnose, and manage chronic diseases 22 . Telemedicine has been shown to be safe and offers the potential for cost-effective healthcare, personalised service, and convenience for both patients and healthcare providers [23] [24] [25] [26] . The aims of the rheumatology VMC are to allow stable rheumatology patients to continue with monitoring without having to make too many trips to the hospital or clinic, free-up clinic space, and improve patients' satisfaction by reducing cost and waiting time. The VMC commenced in July 2012 and aims to enroll approximately 400 patients over a one-year period. The referral criteria to the VMC are somewhat similar to that of the RMC, which primarily includes patients with stable rheumatoid arthritis or spondyloarthritis, who need drug monitoring and hence cannot be discharged to primary healthcare. In addition, VMC patients need to have access to a phone or short message service. The VMC protocol and process algorithm (Fig. 1) is based on the earlier well-established RMC protocol. Eligible patients are invited to participate in the VMC by a research coordinator if they are deemed suitable by the attending rheumatologist during their routine specialist outpatient visits. In the VMC, blood tests are performed off-site at primary healthcare clinics, such as government polyclinics nearest to their homes, at pre-determined regular intervals. The APN in charge of the VMC will review the blood test results and subsequently contact patients over the phone to ask about symptoms and provide advice as needed. If the results are within the normal range, the APN will activate the Pharmacy Home Delivery Service to courier the medication to the patient. However, if the results are abnormal, or reflect toxicity, the APN will inform the rheumatologist and discuss further action. The main advantage of this virtual clinic is that the patients need not make a trip to the hospital for their VMC appointment. Patients have direct phone access to the APN for teleadvice or support in between VMC appointments. Prospective data collection is being carried out to measure clinical outcomes, access to care, patient satisfaction, quality of life, and cost-effectiveness. With the introduction of VMC, current on-site RMC will continue its operation for patients who prefer to meet the APN/pharmacist in person, or patients who do not meet criteria for the VMC.
CONCLUSION
The rise in chronic disease worldwide has brought about a greater demand for healthcare and the need for changes in healthcare provision. Although the APN/pharmacist-led RMC is a novel service in Singapore, we established the acceptability of this non-physician-led clinic in our local setting, and highlighted the usefulness of having a routine clinic for monitoring medication toxicity and patient counselling. Other elements of this service which reflect best practice is the strong positive feedback received from patients, rheumatologists, and allied health professionals, with a high degree of satisfaction among the respondents. In addition, the RMC has shown promise in freeing up clinic slots for rheumatologists to see more new patients or those with complex medical conditions. With the emerging trend towards using information technology in chronic disease management, the rheumatology VMC has been introduced to offer convenient and cost-effective healthcare to patients. In order to prove the usefulness of the RMC and VMC, and why these clinic models should be adopted universally, a stronger research methodology would be necessary; for example, studying other useful health service related outcomes such as number of specialist clinic slots
